Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Valeant Pharmaceuticals International Inc T.VRX

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  VRX

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
Price: $312.05 Volume: 369,240
Change: +$1.60 % Change: +0.52%
Day High/Low: 313.55/307.96 52 Week High/Low: 347.84/125.50
Last Traded: August 28, 2015 12:00 Transaction Volume: 84
Open: 310.05 Previous Close: 310.45
Bid: 312.03 Ask: 312.87
Bid Size: 100 Ask Size: 500
Market Cap: 106.5b Shares Out: 341.2m
PE Ratio: 107.4 Dividend Yield: N/A

Latest Bullboard Posts

  • Some Still Quite Happy

    0 stars

    Mr. Pearson has nearly five million stock options, some exercisable, some not, with profit of $1.2-billion at Thursday's New York close...

    1.5 stars


  • RE:Zack's rating on Valeant

    0 stars

    stockboy Rule Number 1 for investing: NEVER LISTEN TO ANALYSTS. Valeant stock has another 20 to 30% drop in the works. Watch and learn...

    2 stars


  • More deals for Valeant

    0 stars

    If not for acquisitions, Valeant Pharmaceuticals (NYSE:VRX) would hardly make it on a map of large and fast-growing drug companies. But...

    3.5 stars


  • Zack's rating on Valeant

    0 stars

    As much as 10 analysts have advised buy on Valeant Pharmaceuticals International, Inc. (NYSE:VRX) with an average broker rating of 1.55...

    3.5 stars


  • Zack's rating on Valeant

    0 stars

    JPMorgan Chase & Co. Reiterates “Buy” Rating for Valeant Pharmaceuticals Intl (VRX) Posted by Pezhman Azimi on Jul 28th, 2015 // No...

    3.5 stars